A trial looking at treatment for people with myeloma that has come back or stopped responding to treatment

This trial looked at bortezomib with or without siltuximab for myeloma. It was for people who’d already had treatment, but their myeloma had come back or started to get worse.

The trial was open in 18 countries for people to join between 2006 and 2009. The team published the results in 2015. There is a link to more information in the ‘Summary of results’ section below.